TMPRSS2-ETS fusion prostate cancer: Biological and clinical implications

被引：40

作者：

Demichelis, Francesca

Rubin, Mark A.

机构：

[1] Harvard Univ, Sch Med, Boston, MA USA

[2] Brigham & Womens Hosp, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL PATHOLOGY | 2007年 / 60卷 / 11期

关键词：

D O I：

10.1136/jcp.2007.046557

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：1185 / 1186

页数：2

共 22 条

[1] How well does the gleason score predict prostate cancer death?: A 20-year followup of a population based cohort in Sweden [J].

Andrén, O ;

Fall, K ;

Franzén, L ;

Andersson, SO ;

Johansson, JE ;

Rubin, MA .

JOURNAL OF UROLOGY, 2006, 175 (04) :1337-1340

[2] Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer [J].

Carver, Brett S. ;

Bianco, Fernando J., Jr. ;

Scardino, Peter T. ;

Eastham, James A. .

JOURNAL OF UROLOGY, 2006, 176 (02) :564-568

[3] TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions [J].

Cerveira, Nuno ;

Ribeiro, Franclim R. ;

Peixoto, Ana ;

Costa, Vera ;

Henrique, Rui ;

Jeronimo, Carmen ;

Teixeira, Manuel R. .

NEOPLASIA, 2006, 8 (10) :826-832

[4] TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort [J].

Demichelis, F. ;

Fall, K. ;

Perner, S. ;

Andren, O. ;

Schmidt, F. ;

Setlur, S. R. ;

Hoshida, Y. ;

Mosquera, J-M ;

Pawitan, Y. ;

Lee, C. ;

Adami, H-O ;

Mucci, L. A. ;

Kantoff, P. W. ;

Andersson, S-O ;

Chinnaiyan, A. M. ;

Johansson, J-E ;

Rubin, M. A. .

ONCOGENE, 2007, 26 (31) :4596-4599

[5] Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program [J].

Hayat, Matthew J. ;

Howlader, Nadia ;

Reichman, Marsha E. ;

Edwards, Brenda K. .

ONCOLOGIST, 2007, 12 (01) :20-37

[6] TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming [J].

Iljin, Kristiina ;

Wolf, Maija ;

Edgren, Henrik ;

Gupta, Santosh ;

Kilpinen, Sami ;

Skotheim, Rolf I. ;

Peltola, Mari ;

Smit, Frank ;

Verhaegh, Gerald ;

Schalken, Jack ;

Nees, Matthias ;

Kallioniemi, Olli .

CANCER RESEARCH, 2006, 66 (21) :10242-10246

[7] Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer [J].

Laxman, Bharathi ;

Tomlins, Scott A. ;

Mehra, Rohit ;

Morris, David S. ;

Wang, Lei ;

Helgeson, Beth E. ;

Shah, Rajal B. ;

Rubin, Mark A. ;

Wei, John T. ;

Chinnaiyan, Arul M. .

NEOPLASIA, 2006, 8 (10) :885-888

[8] Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer [J].

Mehra, Rohit ;

Tomlins, Scott A. ;

Shen, Ronglai ;

Nadeem, Owais ;

Wang, Lei ;

Wei, John T. ;

Pienta, Kenneth J. ;

Ghosh, Debashis ;

Rubin, Mark A. ;

Chinnaiyan, Arul M. ;

Shah, Rajal B. .

MODERN PATHOLOGY, 2007, 20 (05) :538-544

[9] Morphological features of TMPRSS2-ERG gene fusion prostate cancer [J].

Mosquera, J-M ;

Perner, S. ;

Demichelis, F. ;

Kim, R. ;

Hofer, M. D. ;

Mertz, K. D. ;

Paris, P. L. ;

Simko, J. ;

Collins, C. ;

Bismar, T. A. ;

Chinnaiyan, A. M. ;

Rubin, M. A. .

JOURNAL OF PATHOLOGY, 2007, 212 (01) :91-101

[10] Expression of TMPRSS2 ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression [J].

Nam, Robert K. ;

Sugar, Linda ;

Wang, Zhenghui ;

Yang, Wenyi ;

Kitching, Richard ;

Klotz, Laurence H. ;

Venkateswaran, Vasundara ;

Narod, Steven A. ;

Seth, Arun .

CANCER BIOLOGY & THERAPY, 2007, 6 (01) :40-45

← 1 2 3 →